Articles
Dealing with misconduct at Japanese companies – when and how to engage with regulators
(July 2022)
Kensuke Suzuki, John Lane (Co-author)
- Global Investigations / Crisis Management / Compliance
Publications
Kensuke Suzuki: Publications
-
-
Articles
Chambers Global Practice Guides Life Sciences 2022 Japan – Law & Practice
(April 2022)
Kenji Utsumi, Kensuke Suzuki (Co-author)
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences
-
Articles
Chambers Global Practice Guides Life Sciences 2021 Japan – Law & Practice
(March 2021)
Kenji Utsumi, Kensuke Suzuki (Co-author)
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences
-
Articles
Medicinal product regulation and product liability in Japan: overview (2020)
(December 2020)
Kenji Utsumi, Kensuke Suzuki (Co-author)
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences
-
Articles
Japanese government considering new legislative measures to provide for indemnification regarding COVID-19 vaccine use
(November 2020)
Kensuke Suzuki, Yoshinobu Koyama (Co-author)
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences
-
Articles
Chambers Global Practice Guides Life Sciences 2020 Japan – Law & Practice
(March 2020)
Kenji Utsumi, Kensuke Suzuki (Co-author)
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences
-
Books
“Advanced Financial Instruments and Exchange Act, 3rd Edition”
Shojihomu Co., Ltd. (August 2019)
Edited by Nagashima Ohno & Tsunematsu, Hiroyuki Ishizuka, Kazuo Mizutani, Masaki Konishi, Shigeki Minami, Masatsura Kadota, Keiko Shimizu, Taku Umezawa, Kensuke Suzuki, Shinichi Araki, Atsushi Sakai, Atsushi Yamashita, Ohki Mizuno, Kazuya Ogawa, Sosuke Kimura, Motoki Saito
- Finance
- Financial Regulations
-
Articles
Medicinal product regulation and product liability in Japan: overview (2019)
(July 2019)
Kenji Utsumi, Kensuke Suzuki (Co-author)
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences
